A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of Life

Completed

Conditions studied: Chronic Kidney Disease

In brief

DISCOVER CKD is an international observational cohort study in patients with CKD, comprising both prospective and retrospective patient cohorts. The study does not attempt to test any specific a priori hypotheses, is largely descriptive, and utilises data collected only under conditions of routine clinical care.

Key facts

Study ID: NCT04034992
Run by: AstraZeneca
People needed: 1052
Starts: 2019-09-11
Expected to finish: 2023-06-30
Last updated by the study team: 2024-03-06

Who can join

Age: 18 and older, up to 130. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

For all countries, except Japan: Male or female patients aged 18 years and over. For Japan: Male or female patients aged 20 years and over.
First documented diagnostic code (eg, International Classification of Diseases-10) of CKD (Stages 3A, 3B, 4, 5, or end stage renal disease) or two measures of eGFR of <75mL/min/1.73 m\^2 recorded at least 90 days apart on or after 1 January 2008, or a code for chronic Renal replacement therapy (hemodialysis and peritoneal dialysis), whichever comes first.
Provision of written informed consent - specific for prospective data capture.

You may not qualify if…

Concurrent participation in any interventional trial at baseline (index) (prospective only). To be implemented based on local regulatory requirements.
The patient is undergoing treatment for active cancer, except for non-melanoma skin cancer.
Patients with a life expectancy of less than 12 months (prospective only).
Diagnosis of cancer on or within the 1-year prior to index (retrospective only).
Less than 1-year registration/medical history (pre-index) (retrospective only).

Where it is running

Research Site — Riverside, California, United States
Research Site — San Francisco, California, United States
Research Site — Sanford, Florida, United States
Research Site — Sebring, Florida, United States
Research Site — Plymouth, Massachusetts, United States
Research Site — Manhasset, New York, United States
Research Site — The Bronx, New York, United States
Research Site — Roseburg, Oregon, United States
Research Site — El Paso, Texas, United States
Research Site — Houston, Texas, United States
Research Site — San Antonio, Texas, United States
Research Site — Rome, Lazio, Italy
Research Site — Milan, Lombardy, Italy
Research Site — Bologna, Italy
Research Site — Modena, Italy
Research Site — Naples, Italy
Research Site — Nagoya, Aiti [Aichi], Japan
Research Site — Kashihara-shi, Nara, Japan
Research Site — Kurashiki, Okayama-ken, Japan
Research Site — Itabashi-Ku, Tôkyô [Tokyo], Japan
Research Site — Kumamoto, Japan
Research Site — Okayama, Japan
Research Site — Osaka, Ôsaka [Osaka], Japan
Research Site — Ferrol, A Coruña, Spain
Research Site — Santiago de Compostela, A Coruña, Spain

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.